STEPHEN M. MAURER

2607 Hearst Ave, MC 7320

University of California

Berkeley, CA. 94720

(510) 642-6511

smaurer@.berkeley.edu


 

================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================

 

 

EDUCATION:

 

Yale University (1979).  B.A., summa cum laude.

 

Harvard Law School (1982).  J.D.

 

U.C. Berkeley (1997).  Advanced coursework in Economics.

 

 

 

EXPERIENCE:

 

§          Academic Research.  Adjunct Associate Professor, Goldman School of Public Policy and Berkeley Law School. Original published research on open source biology (Public Library of Science - Medicine), R&D incentives for drug development (WHO Bulletin), database policy (Nature, Science), patent law (Economica), and academic/industry transactions (Research Policy). Lead editor and author, WMD Terrorism: Science and Policy Choices (MIT Press 2009).

 

 §          Teaching.  University of California (Berkeley) Adjunct professor, presenting graduate-level courses on Internet law, economics, and technology (Designing Strategies for Neglected Disease Research , History of Computing, Public Policy for Engineers, Cyberlife, Science Policy, and Information Technology and Public Policy) and Homeland Security (Synthetic Biology and Security, Introduction to Homeland Security).  Invited speaker at intellectual property conferences hosted by US National Academy of Sciences, US National Institutes of Health, US Department of Transportation, The Human Genome Organization, Duke University Law School, Stanford University, and The University of California, Berkeley.

 

 §          Policy Consultant. Performed sponsored research for The US National Academy of Sciences (academic/industrial research agreements; database protection legislation), Industry Canada (US and European database policies), and World Health Organization (R&D incentive design for neglected disease research). Co-led initiative by 650 academic biologists to build $2.3 million open database in partnership with Incyte Pharmaceutical Company. Partnered with leading trade association (International Association - Synthetic Biology) to draft and implement a formal Code of Conduct definining member obligations to screen incoming orders for possible biosecurity threats.

 

§          Intellectual Property Attorney. Practiced intellectual property and high technology litigation at leading law firms from 1982 to 1997.  Clients including IBM (computer hardware), Apple Computer and Symantec (software), ROLM (computerized telephone systems), UTC (advanced composite irrigation pipe), Zilog (semiconductor chip design), Tegal Corporation (microchip fabrication tools), Aerojet General Corporation (rocket engines), and The Navajo Nation (boundary dispute).

 

§          Related Skills.  Published feature articles and/or cover story for Sky & Telescope and Stanford Linear Accelerator Center’s Beam Line magazine.  

 

 

ACADEMIC PUBLICATIONS

 

S. Maurer, "Stepping Stones: Extending the Open Source Idea to Synthetic Biology." 2012. Conference Paper: Sybhel Workshop on Synthetic Biology and Human Health. The Hague.

 

S. Maurer, "Taking Self-Governance Seriously: Synthetic Biology's Last, Best Chance to Improve Security." Conference Paper: Synthetic Biology for Global Health. Rathenau Institute, The Hague.

 

S. Maurer, "Regulation Without Government: European Biotech, Private Anti-Terrorism Standards, and the Idea of Strong Self-Governance," Schriften des Münchner Centrums für Governance-Forschung (Munich Center for Governance Research Publications Series: 2012).

S. Maurer, "The Penguin and the Cartel: Rethinking Antitrust and Innovation Policy for the Age of Commercial Open Source," Utah Law Review (forthcoming: Spring 2012).

S. Maurer, "End of the Beginning or Beginning of the End? Synthetic Biology’s Stalled Security Agenda and the Prospects for Restarting It," Valparaiso University Law Review 45(4): 1387-1446 (2011).

S. Maurer, "Beyond Treaties and Regulation: Using Market Forces to Control Dual Use Technologies," GSPP Working Paper (2010).

S. von Englehardt, S. Freytag, and S. Maurer, Open vs. Closed Source Software: The Quest for Balance, Vox (2010).

S. Maurer, "The Penguin and the Cartel: Rethinking Antitrust and Innovation Policy for the Age of Commercial Open Source," GSPP Working Paper (2010).

S. Maurer, "Five Easy Pieces: Case Studies of Entrepreneurs Who Organized Private Communities for a Public Purpose," Conference paper, George Washington University Law School.

S. Maurer and S. von Engelhardt, "The New (Commercial) Open Source: Does It Really Improve Social Welfare?" GSPP Working Paper (2010).

 

J. Henkel and S. Maurer, "Network Effects in Biology" American Economic Review: Papers and Proceedings, 100:159-64 (2010).

 

J. Henkel and S. Maurer, "Network Effects in Biology." ITHS Working Paper (2009).

 

S. Maurer and M. Fischer, "Harmonizing Biosecurity Oversight for Gene Synthesis," Nature Biotechnology 28:20-22 (2010).

 

S. Maurer, "Using University Knowledge to Defend the Country," Issues in Science and Technology Winter 2010: 27-30.

 

S. Maurer, "How to Control Dual-Use Technologies in the Age of Global Commerce," Bulletin of the Atomic Scientists (January/February 2010: 41-47.

 

J. Henkel and S. Maurer, "Parts, Property, and Sharing," Nature Biotechnology 27:1095-1098 (2009).

 

S. Maurer, "Gene Synthesis Industry’s Continuing Fight Over Biosecurity Standards," Bioethics Forum (2009).

 

S. Maurer, "Synthetic Biology Marketplace: Screening Out Terrorists" Bioethics Forum (2009).

 

S. Maurer, M. Fischer, H. Schwer, C. Stähler, and P. Stähler, Making Commercial Biology Safer: What the Gene Synthesis Industry Has Learned About Screening Customers and Orders, (ITHS Working Paper 2009).

 

S. Maurer, "Before It's Too Late: Why Synthetic Biologists Need an Open Parts Collaboration - And How to Build One," European Molecular Biology Organization Reports 10:806-809 (2009).

 

L. Ortí, R.Carbajo, U.Pieper, N.Eswar, S. Maurer, A.Rai, G.Taylor, M.Todd, A.Pineda-Lucena, A.Sali, and Marc Marti-Renom, "A Kernel for Open Source Drug Discovery in Tropical Diseases," Public Library of Science : Neglected Tropical Diseases 3:418 (2009).

 

L. Ortí, R.Carbajo, U.Pieper, N.Eswar, S. Maurer, A.Rai, G.Taylor, M.Todd, A.Pineda-Lucena, A.Sali, and Marc Marti-Renom, "A Kernel for the Tropical Disease Initiative," Nature Biotechnology 27:320 (2009).

 

S. Maurer, "Grassroots Efforts to Impede Bioterrorism," Bulletin of the Atomic Scientists (March 5, 2009).

 

S. Maurer, "Introduction: Worrying about WMD Terrorism," Chapter 1 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

S. Maurer, "Technologies of Evil: Chemical, Biological, Radiological, and Nuclear Weapons," Chapter 3 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

George W. Rutherford and S. Maurer, "The New Bioweapons: Infectious and Engineered Diseases," Chapter 4 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

S. Maurer, Jason C. Christopher, and Michael Thompson, "The Fire Next Time: Managing Large Urban Fires, " Chapter 10 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

S. Maurer, "Squeezing Value from Homeland Security Research: Designing Better R&D Incentives," Chapter 15 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

S. Maurer and Michael O'Hare, "Fear Itself: Predicting and Managing Public Response to a WMD Attack," Chapter 16 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

S. Maurer, "Summing Up," Chapter 18 in S. Maurer (ed.), WMD Terrorism: Science and Policy Choices, MIT Press (2009).

 

S. Maurer, "Open Source Drug Discovery: Finding a Niche (or Maybe Several)," University of Missouri at Kansas City Law Review 76:405-435 (2007).

S. Maurer & L. Zoloth, "Synthesizing Biosecurity," Bulletin of the Atomic Scientists, (Nov. 2007).

J. Henkel & S. Maurer, "The Economics of Synthetic Biology," Molecular Systems Biology 3:117 (2007).

 

S. Maurer & S. Scotchmer, "Profit Neutrality in Licensing: The Boundary Between Antitrust Law and Patent Law," American Law and Economics Review 8:476 (2007).

 

S. Maurer, K. Lucas & S. Terrell, "From Understanding to Action: Community-Based Options for Increasing Safety and Security in Synthetic Biology," (ITHS Working Paper 2006).

 

S. Maurer, "Inside the Anticommons: Academic Scientists' Struggle to Commercialize Human Mutations Data, 1999-2001," Research Policy 35:839 (2006) .  

 

S. Maurer & S. Scotchmer, "Open Source Software: The New Intellectual Property Paradigm," in T. Hendershott (ed.), Handbook on Information Systems (Elsevier: 2006).

 

S. Maurer, "Choosing the Right Incentive Strategy for R&D in Neglected Diseases," World Health Organization Bulletin 84:376 (2006).

 

S. Maurer, "The Right Tool(s): Designing Cost-Effective Strategies for Neglected Disease Research," paper commissioned by World Health Organization (2005).

 

S. Maurer, A. Sali & A. Rai, “Finding Cures for Tropical Disease: Is Open Source the Answer?,Public Library of Science: Medicine 1:56 (2004).

 

US National Academy of Sciences Committee on Geophysical Data, Licensing Geographic Data and Services (National Academies Press 2004).

 

S. Maurer & S. Scotchmer, "Procuring Knowledge," in G. Libecap (ed.), Advances in the Study of Entrepreneurship, Innovation and Growth: Vol. 15, at p. 1 (JAI Press 2004).

 

S. Scotchmer & S. Maurer, "Institutions: A Brief Excursion Through History," in S. Scotchmer, Innovation and Incentives (MIT Press: 2004).

 

S. Maurer, "New Institutions for Doing Science: From Databases to Open Source Biology", conference paper, University of Maastricht (2003).

 

S. Maurer & S. Scotchmer, “The Independent Invention Defense in Intellectual Property,”  Economica 69:535 (2002)  (lead article).

 

S. Maurer, “Promoting and Disseminating Knowledge: The Public/Private Interface,” paper commissioned by the US National Academy of Sciences (2002).

 

S. Maurer, P.B. Hugenholtz & H. Onsrud, “Europe’s Database Experiment,Science 294:789 (2001).

 

S. Maurer, “Across Two Worlds: US and European Models of Database Protection,” paper commissioned by Industry Canada (2001).

 

S.  Maurer, R. Firestone & C. Scriver, “Science’s Neglected Legacy Nature 405:117 (2000).

 

S. Maurer, “Coping With Change: Intellectual Property Rights, New Legislation, and the Human Mutations Database Initiative,” 15 Human Mutations 23 (2000).

 

S.  Maurer, “Protecting What’s Yours: The Law and Economics of Geospatial Data,” 10 GeoInfoSystems 36 (2000).

 

S. Maurer, “Interdisciplinary Data,” talk presented at US National Academy of Sciences/CODATA “National Conference on Scientific and Technical Data,” Washington D.C., March, 2000. 

 

S. Maurer & S. Scotchmer, “Database Protection: Is it Broken and Should We Fix It?Science 284:1129 (1999).

 

S. Maurer, Raw Knowledge: Protecting Technical Databases for Science & Industry,” paper commissioned by the US National Academy of Sciences  (1999).

 

 

POPULAR PUBLICATIONS:

 

S. Maurer, Selected Blogs, The Berkeley Blog (2009 - ).

 

S. Maurer, Blog: "Sharp Pencil Compassion: Fixing Government-Funded Drug and Vaccine Research, in Blue Sky: New Ideas for the Obama Administration (2009).

 

S. Maurer & D. Howell, “Anatomy of a Supernova,” Sky & Telescope (November 2002) (cover story).

 

S.  Maurer, “Taking the Pulse of Neutron Stars,” Sky & Telescope (August 2001) (nuclear astrophysics).

 

S.  Maurer, “Idea Man,” Beam Line (Winter 2001) (astronomer Fritz Zwicky)

 

 

SPEAKER:

 

Research Insitute of Industrial Economics - Innovation, Ownership & Competition Policy Workshop (June 2010); Friedrich Schiller University - Workshop on Open Source, Innovation, and Entrepreneurship (Jan. 2010); American Economics Association Annual Meeting (Jan. 2010); Global Economic Symposium (Sept. 2009); Hastings Law School - Bay Area IP Law Professors Meeting (January 2009); UN Biological Weapons Convention/Meeting of States Parties (December, 2008); Synthetic Biology 4.0 (October 2008); Boalt Hall Law School Innovation Scholarship Seminar (September 2008); US Government Roundtable on Development of a Synthetic Nucleic Acid Screening Framework (September, 2008); IASB Workshop on Technical Solutions for Biosecurity in Synthetic Biology (April 2008); New York University Law School (January 2008); Synthetic Biology 3.0 (June 2007); European School on New Institutional Economics (June 2007); World Affairs Council Annual Conference ("Rethinking the War on Terror") (May 2007); Wisconsin Stem Cell Institute (March 2007); UC Berkeley China/India/Russia Conference (October 2006); UC Berkeley Constitution Day (September 2006); AAAS Wye River Biosecurity Conference (Sept. 2006); Institute on Global Conflict and Cooperation Biosecurity Summer School (June 2006); Synthetic Biology 2.0 (May 2006); California's Stem Cell Initiative (March 2006); Berkeley Symposium on Real Estate and Catastrophic Risk (May 2006); Temple University Law School Conference on Evolution of Open Source (February 2006);Stanford Medical School (January 2006); Medecins sans Frontieres, Access Campaign for Essential Medicines (June 2005); Duke Workshop on Collective Computational Biology for Neglected Diseases (May 2005); International Conference on Pharmaceutical Innovation (May cFoundation (June 2004); US National Academy of Sciences (March 2000, August 2002, and Sept.2009); The University of Auckland (August 2002); The University of California at Berkeley (March 2006, March and October 2001); Duke Law School (November 2001 and May 2007); Industry Canada (May 2001); The Mutation Database Initiative (October 1999, April 2000, and October 2000); The American Association of Geographers (November 1999).  

 

 

POLICY ADVISOR:

 

Member, US National Academy of Sciences Committee on Geophysical Data (2003-2004).  Co-author, Licensing Geographic Data and Services (National Academies Press 2004), Advisor, World Health Organization (2004), US National Academy of Sciences (1999, 2002, and 2007), Industry Canada (2001), National Institutes of Health (September 2000), Transportation Research Board Workshop on Public Agency Use of Proprietary Geographic Base Files,” (2000), and Incyte Pharmaceutical Company “Workshop on an Integrated Genomics Software Architecture,” (2000).

 

MEDIA COVERAGE:

 

M. Wadman, "US Drafts Guidelines to Screen Genes," Nature News (Dec. 4, 2009).

 

E. Check Hayden, "Gene Makers Form Security Coalition," Nature News (Nov. 18, 2009).

 

C. Lok, "Gene-Makers Put Forward Security Standards," Nature News (Nov. 4, 2009)

 

E. Check Hayden, "Keeping Genes Out of Terrorists' Hands," Nature 461:22 (Sept. 3, 2009).

 

B. Bergman, "Goldman School portal takes the worry out of 'experiments of concern," The Berkeleyan (April 2, 2009).

 

P. Aldhous, "Are Fears Over Bioterrorism Stifling Scientific Research?" New Scientist (Feb. 5, 2009).

 

E. Check Hayden, "Experiments of Concern to Be Vetted On Line," Nature 457:643 (Feb. 5, 2009).

 

______, "DNA Firms Step Up Security Over Bioterrorism," New Scientist (Sept. 10, 2008).

 

______, "Fifty People Who Matter Now," Business 2.0 (June 2006) (ranked at 41).

 

R. Service, "Synthetic Biologists Debate Policing Themselves," Science 312:1116 (May 26, 2006).

 

P. Aldhous, "Synthetic Biologists Reject Controversial Guidelines," New Scientist (May 23, 2006).

 

N. Johnson, "Steal This Genome!," East Bay Express 25:13 (March 30, 2005).

 

______, “Open Wide – This Won’t Hurt a Bit,” Red Herring (Jan. 31 2005).

 

K. Cukier " An Open Source Shot in the Arm? " The Economist (June 10, 2004).

 

K. Miller, “Innovation Sales Free,” Newsweek (international edition) and MSNBC.com  (Oct. 18, 2004).

 

A. Huang & C. Weber, “The Health of Nations: Open-Source Research and the Economics of Life and Death in the Developing World,” Berkeley Science Review 7:45 (Fall, 2004).  

 

 

 

CHRONOLOGY:  

 

2005 - 2009                Adjunct Professor, Goldman School of Public Policy and Boalt Law School.

 

1999-2004                   Lecturer, Goldman School of Public Policy, University of California, Berkeley.

 

1998                            Senior Associate, Fliesler, Dubb, Meyer & Lovejoy, San Francisco, CA.

 

1997                            Sabbatical: advanced courses in economics, U.C. Berkeley.

 

1994-1996                   Senior Associate, Ritchey, Fisher, Whitman & Klein, Palo Alto, CA.

 

1992-1994                   Contract Attorney, San Francisco and Palo Alto, CA.

 

1988-1992                   Senior Associate, Lasky, Haas, Cohler & Munter, San Francisco, CA.

   

1982-1987                   Associate.  Brown & Bain, Phoenix, AZ.